NCT00943709View on ClinicalTrials.gov

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
HyperglycemiaLeukemia
Interventions
BIOLOGICAL

insulin glargine recombinant

Given subcutaneously

DRUG

therapeutic insulin

Given subcutaneously

Trial Locations (1)

08903

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Sanofi

INDUSTRY

lead

University of Medicine and Dentistry of New Jersey

OTHER

NCT00943709 - Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia | Biotech Hunter | Biotech Hunter